ZNF217 is a candidate oncogene located on chromosome 20q13.2, a region that is frequently amplified in many tumors, including those of the breast, colon, glioma, ovarian and prostate [8–10, 17, 29–31]. This evidence concerns the gene ZNF217 and central nervous system cancer.